Cargando…

Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report

BACKGROUND: We report a case of macular hole (MH) formation and retinal detachment after intravitreal conbercept injection for the treatment of choroidal neovascularization (CNV) secondary to degenerative myopia. CASE PRESENTATION: A 60-year-old woman presented with blurred vision in her left eye wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun , Chuan-bin, Wang, Yueye, Zhou, Shiyang, Fang, Xudong, Xu, Danni, Liu, Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647155/
https://www.ncbi.nlm.nih.gov/pubmed/31331298
http://dx.doi.org/10.1186/s12886-019-1164-4
_version_ 1783437668071243776
author Sun , Chuan-bin
Wang, Yueye
Zhou, Shiyang
Fang, Xudong
Xu, Danni
Liu, Zhe
author_facet Sun , Chuan-bin
Wang, Yueye
Zhou, Shiyang
Fang, Xudong
Xu, Danni
Liu, Zhe
author_sort Sun , Chuan-bin
collection PubMed
description BACKGROUND: We report a case of macular hole (MH) formation and retinal detachment after intravitreal conbercept injection for the treatment of choroidal neovascularization (CNV) secondary to degenerative myopia. CASE PRESENTATION: A 60-year-old woman presented with blurred vision in her left eye was diagnosed as CNV secondary to degenerative myopia. Intravitreal injection of conbercept, an anti -vascular endothelial growth factor (VEGF) agent, was uneventfully performed in the left eye. Unfortunately, a full thickness MH and retinal detachment was found three weeks postoperatively by ophthalmoscopy and spectral-domain optical coherence tomography. Vitrectomy, internal limiting membrane peeling and silicone oil tamponade were then performed, and macular retina was reattached soon after surgery. However, MH still kept open during three months’ follow-up. CONCLUSION: MH is a quite rare complication of intravitreal anti- VEGF agent injection, tangential contraction secondary to CNV shrinkage and regression caused by anti-VEGF agent is proposed to be the major pathogenesis of MH formation.
format Online
Article
Text
id pubmed-6647155
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66471552019-07-31 Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report Sun , Chuan-bin Wang, Yueye Zhou, Shiyang Fang, Xudong Xu, Danni Liu, Zhe BMC Ophthalmol Case Report BACKGROUND: We report a case of macular hole (MH) formation and retinal detachment after intravitreal conbercept injection for the treatment of choroidal neovascularization (CNV) secondary to degenerative myopia. CASE PRESENTATION: A 60-year-old woman presented with blurred vision in her left eye was diagnosed as CNV secondary to degenerative myopia. Intravitreal injection of conbercept, an anti -vascular endothelial growth factor (VEGF) agent, was uneventfully performed in the left eye. Unfortunately, a full thickness MH and retinal detachment was found three weeks postoperatively by ophthalmoscopy and spectral-domain optical coherence tomography. Vitrectomy, internal limiting membrane peeling and silicone oil tamponade were then performed, and macular retina was reattached soon after surgery. However, MH still kept open during three months’ follow-up. CONCLUSION: MH is a quite rare complication of intravitreal anti- VEGF agent injection, tangential contraction secondary to CNV shrinkage and regression caused by anti-VEGF agent is proposed to be the major pathogenesis of MH formation. BioMed Central 2019-07-22 /pmc/articles/PMC6647155/ /pubmed/31331298 http://dx.doi.org/10.1186/s12886-019-1164-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Sun , Chuan-bin
Wang, Yueye
Zhou, Shiyang
Fang, Xudong
Xu, Danni
Liu, Zhe
Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report
title Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report
title_full Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report
title_fullStr Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report
title_full_unstemmed Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report
title_short Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report
title_sort macular hole retinal detachment after intravitreal conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647155/
https://www.ncbi.nlm.nih.gov/pubmed/31331298
http://dx.doi.org/10.1186/s12886-019-1164-4
work_keys_str_mv AT sunchuanbin macularholeretinaldetachmentafterintravitrealconberceptinjectionforthetreatmentofchoroidalneovascularizationsecondarytodegenerativemyopiaacasereport
AT wangyueye macularholeretinaldetachmentafterintravitrealconberceptinjectionforthetreatmentofchoroidalneovascularizationsecondarytodegenerativemyopiaacasereport
AT zhoushiyang macularholeretinaldetachmentafterintravitrealconberceptinjectionforthetreatmentofchoroidalneovascularizationsecondarytodegenerativemyopiaacasereport
AT fangxudong macularholeretinaldetachmentafterintravitrealconberceptinjectionforthetreatmentofchoroidalneovascularizationsecondarytodegenerativemyopiaacasereport
AT xudanni macularholeretinaldetachmentafterintravitrealconberceptinjectionforthetreatmentofchoroidalneovascularizationsecondarytodegenerativemyopiaacasereport
AT liuzhe macularholeretinaldetachmentafterintravitrealconberceptinjectionforthetreatmentofchoroidalneovascularizationsecondarytodegenerativemyopiaacasereport